Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

High expression of shMDG1 gene is associated with low metastatic potential of tumor cells

Abstract

Metastasis is the primary cause of mortality associated with cancer. Molecular mechanisms leading to metastatic spread are poorly studied. To get a better understanding of this process, we compared the gene expression pattern of two isogenic cell lines, HET-SR and HET-SR1 (Rous Sarcoma Virus-transformed embryo hamster fibroblasts) with different metastatic activity using the differential display technique. A novel cDNA of hamster gene shMDG1 (Syrian hamster homologue of microvascular differentiation gene 1), which had 94% homology with rat MDG1 gene, was identified. Expression of shMDG1 was increased in low metastatic HET-SR cell line in comparison to high metastatic HET-SR1. Sequence analysis of the ORF of shMDG1 gene showed that it belongs to the DnaJ/heat-shock proteins of 40 kDa (HSP40) chaperones family, considered to function as a cochaperone of HSP70 family. In order to confirm involvement of shMDG1 in metastasis, we injected parental and shMDG1 overexpressed cells into animals. We showed that overexpression of the shMDG1 gene significantly diminished the metastatic activity of both HET-SR and HET-SR1 cells. The shMDG1-induced repression of metastasis was not connected with alterations in cell proliferation and motility in vitro, but correlated well with a decrease in content of the Asn-linked β1–6 branched oligosaccharides on cell surface.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH . (1997). J Virol 71: 6641–6649.

  • Chambers AF, Groom AG, MacDonald IC . (2002). Nat Rev Cancer 2: 563–572.

  • Chepurnykh TV, Shtutman MS, Bykova AV, Yanushevich YG, Tatosian AG . (2000). Cell Mol Biol (Russia) 34: 907–910.

  • Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS . (1987). Science 236: 582–585.

  • Demetriou M, Nabi IR, Coppolino M et al. (1995). J Cell Biol 130: 383–392.

  • Deichman G, Kashleva HA, Kluchareva TE, Matveeva VA . (1989). Int J Cancer 44: 908–910.

  • Dichamp C, Taillibert S, Aguirre-Cruz L, Lejeune J, Marie Y, Kujas M et al. (2004). J Neurooncol 67: 281–285.

  • Gu J, Nishikawa A, Tsuruoka N, Ohno M, Yamaguchi N, Kangawa K et al. (1993). J Biochem 113: 614–619.

  • Hanahan D, Weinberg RA . (2000). Cell 100: 57–70.

  • Liang P, Pardee AB . (1992). Science 257: 967–971.

  • Morimoto RI . (1991). Cancer Cells 3: 295–301.

  • Nicolson GL . (1991). Curr Opin Oncol 3: 75–92.

  • Ohtsuka K, Hata M . (2000). Int J Hyperthermia 16: 231–245.

  • Osawa T, Tsuji T . (1987). Annu Rev Biochem 56: 21–42.

  • Pierce M, Arango J . (1986). J Biol Chem 261: 10772–10777.

  • Prols F, Liehr T, Rinke R, Rautenstrauss B . (1997). Cytogenet Cell Genet 79: 149–150.

  • Prols F, Mayer MP, Renner O, Czarnecki PG, Ast M, Gassler C et al. (2001). Exp Cell Res 269: 42–53.

  • Shen Y, Meunier L, Hendershot LM . (2002). J Biol Chem 277: 15947–15956.

  • Tatosyan A, Yatsula B, Shtutman M, Moinova E, Kaverina I, Musatkina E et al. (1996). Virology 216: 347–356.

  • Thorstensen L, Qvist H, Nesland JM, Giercksky KE, Lothe RA . (2001). Scand J Gastroenterol 36: 1327–1331.

  • Welch WJ . (1990). Stress Proteins in Biology and Medicine. Cold Spring Harbor, NY: Cold Spring Harbor Press, pp. 223–278.

    Google Scholar 

  • Yochem J, Uchida H, Sunshine M, Saito H, Georgopoulos CP, Feiss M . (1978). Mol Gen Genet 4: 9–14.

Download references

Acknowledgements

We are grateful to Dr I Zborovskaya, Dr A Gasparian, Dr N Lazarevich and Dr B Kopnin (Cancer Research Center, Moscow, Russia) for the fruitful discussion, and A Komelkov for excellent technical assistance. This work was funded by the Russian National Fund for Basic Research (05-04-48871).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N Isachenko.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Isachenko, N., Dyakova, N., Aushev, V. et al. High expression of shMDG1 gene is associated with low metastatic potential of tumor cells. Oncogene 25, 317–322 (2006). https://doi.org/10.1038/sj.onc.1209022

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209022

Keywords

This article is cited by

Search

Quick links